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Chronic Urticaria is Frequently Triggered by Focal, Particularly Gastrointestinal
Infection: Analysis of 325 Cases
B.Wedi, V. Novacovic, M. Koerner, and A. Kapp
Department of Dermatology and Allergy, Medical University, Hannover, Germany
We previously demonstrated a high frequency of Helicobacter pylori associated gastritis among 100
patients with chronic urticaria. Now, we carefully analysed 325 patients with chronic urticaria
(mean duration of urticaria 6 SD was 37.6 6 60.7 months) attending our Department of
Dermatology within 4.5 years. 65% were women, 47% had associated angioedema. In 21% add-
itional physical triggering was found (11% dermographism, 4% cold urticaria, 3% cholinergic or
delayed pressure urticaria each, 1% heat urticaria). 98/277 patients (35%) showed positive atopy
screening (Sx1). In 18/141 patients (13%) elevated antibodies to thyroid were found, although
thyroid function was normal. 30/325 patients (9%) gave evidence for pseudoallergic reactions
triggering their urticaria.
In 207/325 patients (64%) a focal infection was identi®ed by laboratory tests and/or special
studies. In 135/207 (65%) gastrointestinal infections were found. 99/207 patients (48%) had
Helicobacter pylori gastritis as assessed by 13C-urea breath test and/or gastroscopy. 36/93 patients
(39%) demonstrated abnormal yersinia-immunoblot. Intestinal candidosis was found in 80/200
patients (40%) whereas stool for O & P was always negative. Chronic ENT and dental focal
infections were found in 28% and 22%, respectively. Other infections were present in 23/207
(11%). 51/325 patients (16%) were classi®ed to have chronic idiopathic urticaria.
Taken together based upon our data obtained in 325 patients we propose a speci®c focal med-
ical history and the assessment of at least Helicobacter pylori infection, yersiniosis, and streptococ-
cal infections (ENT, dental) in the diagnostic management of chronic urticaria.
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Sulfasalazine in the Treatment of Normocomplementemic Lymphocytic Urticarial
Vasculitis
C.Pereira, M.J. JuliaÄo, and C. Chieira
Immuno-Allergy Unity, University Hospital, Coimbra, Portugal
The lymphocyte in®ltration and wall vessel damage report about 20% of chronic urticaria out-
patient. Clinically there are similar pattern to those without vasculitis lesion, but with a poor
response to classic therapy. 70 urticaria vasculitis (UV) patients were selected into 4 pharmaco-
logical methodology during 12 weeks: Group I, 32 with sulfasalazine; Group II, 21 with
methylprednisolone; Group III, 9 with dapsone; and Group IV, 8 with cetirizine. All the groups
were evaluated to clinical symptoms and drug consumption each 2 weeks. The skin biopsies
were also performed at the middle and at the end of the study. A washout period was done
during 2 more weeks and after week 32. In a subsample of each group we also study cellular
markers in skin histology (CD3, CD45RO, CD20, CD15).
We observed a complete clinical resolution in Group I patients, in 22 of 32 patients at week 2;
5 at week 3, 3 at week 4; and the other 2 with partial clinical control. Concerning histology 32
patients reverted to normal. In the ®nal biopsy an increase in percentual CD45RO+ was
observed (similar to that shown in normal skin) accompanied by a decrease in absolute number
of CD3+ cells compared to the initial study. We also observed absence of CD15+ and CD20+
cells at the end of the trial. No clinical recurrence was present after sulfasalazine stopped.
From 21 patients of Group II, 5 presented clinical remission, 11 partial resolution, and no
changes in other 5 patients. Only 4 patients showed normal histology at the end of the study.
No clinical effectiveness were related in Group III and IV.
Our results showed a high ef®cacy of sulfasalazine on UV, with no side-effects and with modu-
latory cellular mechanism in the skin.
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New Role for Mast Cell Tryptase in Cutaneous In¯ammation: Protease-Activated
Receptor-2 Regulates In¯ammatory Responses in the Skin
M.Steinhoff,*² N.W. Bunnett,² and T.A. Luger*
*Department of Dermatology, University of MuÈnster, MuÈnster, Germany; ²Department of Surgery and
Physiology, University of California, San Francisco
This paper reviews the recent knowledge about protease-activated receptor-2 (PAR2), a recep-
tor for mast cell tryptase, and its role during in¯ammation. PAR2 is highly expressed in the
skin of different species and can be detected in epithelial cells, endothelial cells, smooth muscle
cells and various immunocompetent cells. Because tryptase has been shown to play an important
role in mast-cell mediated diseases such as urticaria or allergic asthma, and this protease stimu-
lates PAR2 in transfected cell lines, the aim of the study was to determine whether tryptase
activates PAR2 in different cutaneous cells and may thus regulate in¯ammation. Moreover,
since urticaria is well known to have a neurogenic in¯ammatory component, we tested whether
tryptase mediates neurogenic in¯ammation in the skin via receptor-mediated activation of neu-
ropeptide release from sensory neurons. Finally, regulation of PAR2-mediated cytokine release
was measured in human dermal endothelial cells after stimulation with tryptase. PAR2-immu-
noreativity was detected in keratinocytes, endothelial cells, and dermal immune cells. PAR2 and
tryptase are closely associated in various cells as shown by double immuno¯uorescence.
Tryptase stimulates Ca-mobilisation in keratinocytes and dermal endothelial cells indicating this
receptor is functional. In sensory neurons, PAR2 was detected in sensory neurons, and coloca-
lizes with CGRP or SP. Tryptase and PAR2 agonists increased [Ca2+]i in sensory neurons, and
stimulated CGRP and SP release from sensory nerves. Intracutaneous injection of a PAR2 ago-
nist caused marked oedema and recruitment of neutrophils that was abrogated by antagonists of
CGRP type 1 and SP (neurokinin 1) receptors and by sensory denervation with capsaicin.
Moreover, tryptase modulates cytokine release and expression of adhesion molecule expression
in human dermal endothelial cells via PAR2. In conclusion, PAR2 agonists regulate cutaneous
and in¯ammation by a neurogenic and non-neurogenic mechanism indicating that PAR2 plays
an important role in in¯ammatory skin diseases such as urticaria.
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In¯uenza A Virus Infection Induces Virus Speci®c Mast Cell Degranulation Leading to
Local Anaphylaxis in BALB/c Mice
S.M.Grunewald, M. Teufel, E.B. BroÈcker, and K. Erb*
Department of Dermatology, University of WuÈrzburg, WuÈrzburg, Germany; *Department of Infectious
Biology, University of WuÈrzburg, WuÈrzburggermany
A frequent clinical condition is the development of urticaria or allergic asthma following viral
infection. It is currently unclear how viral infections, which usually lead to TH1 dominated
immune responses, can mediate the development of allergic symptoms, which are thought to be
a result of TH2 responses towards antigens. To address this question we infected BALB/c mice
with in¯uenza virus and 3 weeks later checked for in¯uenza speci®c antibody responses, speci®c
T-helper cell subsets and active cutaneous anaphylaxis after intracutaneous rechallenge with
virus antigen. As expected, in¯uenza infection lead to the induction of in¯uenza speci®c T-
helper 1 type cells secreting high amounts of IFN-g but no detectable IL-4 or IL-5 after in¯u-
enza antigen speci®c restimulation. In addition, high levels of speci®c antibodies of the IgG1,
IgG2a and IgG2b subtype can be detected 3 weeks after in¯uenza infection. In¯uenza speci®c
IgE antibodies were found in very low levels. Interestingly in¯uenza virus speci®c antibodies
were relevant for eliciting allergic symptoms like active cutaneous anaphylaxis following intracu-
taneous virus antigen challenge. In conclusion we show here that virus antigen induces speci®c
mast cell degranulation leading to local anaphylaxis in BALB/c mice. This provides a possible
mechanism to explain infect associated exacerbation of atopic diseases like urticaria or asthma.
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Conditions for Indirect Detection of Functional Auto-Antibodies to Anti-FceRIa:
Basophil Histamine Release (BHR) Using Serum of Patients with Chronic Urticaria
(CU)
A.Keller, M. Kamprad, M. Rytter, U. Haustein, and F.-J. Kleine-Tebbe
Department of Dermatology, University Hospital, Leipzig, Germany
In 1/3 of patients with CU IgG antibodies (Ab) to the a-chain of the high af®nity IgE-receptor
(Anti-FceRIa) have been demonstrated. Anti-FceRIa-Ab are cross-reactive to tetanus toxoid
and are not necessarily anaphylactogenic (Eur J Immunol 29:1139, 1999). Therefore, functional
assays for the detection of crosslinking Ab might be superior compared to immunoassay-based
determination. This study explores appropriate conditions for indirect Anti-FceRIa-Ab detec-
tion by BHR. After dextrane sedimentation mixed leukocytes from selected donors (BHRAnti-
IgE_50% of total histamine) were washed twice before incubated for 40 min at 37°C. After cen-
trifugation (15 min, 4°C, 700 3 g) supernatants were carefully removed and analyzed ¯uome-
trically; cell pellets were disintegrated (2% HClO4) and removed too (15 min, 4°C, 700 3 g),
enabling separation and subsequent detection of released and cellular (nonreleased) histamine to
avoid serum artefacts. Serum (1:2±1:100 diluted) did not modify spontaneous or IgE-mediated
BHR (n = 7) signi®cantly. Screening 50 sera from CU patients, 11 showed dose-dependent
BHR, reproduced with different basophil donors. Removal of basophilic IgE by lactic acid pre-
treatment to open IgE receptors induced a shift of BHR curves of selected sera to lower or
higher concentrations, separating presumably Anti-FceRIa-mediated from IgE-mediated stimuli.
Serum pretreatment (56°C, 3 h) did not abolish BHR, except for one serum, most likely con-
taining Anti-IgE-Ab. Preliminary experiments indicate that selected sera from CU-patients do
not only induce BHR, but also dose dependent sul®do-leukotriene release (assay kindly pro-
vided by DPC Biermann) from IL-3 pretreated basophils. BHR might facilitate screening of
sera for functional Anti-FceRIa- or Anti-IgE-activity permitting further de®nition of their clin-
ical relevance in patients with CU.
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Is Extensive Clinical Examination Relevant for Chronic Urticaria? Results of an In-
Patient Study at Kiel University
C. Garrelfs and M.Sticherling
Department of Dermatology, University of Kiel, Kiel, Germany
Chronic urticaria presents a common, distressing and partly life-threatening disease. Until today,
both pathogenic concepts and therapeutic regimens remain a medical challenge. Consequently,
in individual cases, extensive search for underlying causes is initiated with often disappointing
results. To evaluate serological and clinical markers, data from 339 in-patients with chronic urti-
caria treated at the Department of Dermatology of Kiel University from January 1994 to July
1997 were evaluated retrospectively. Apart from case-history, in¯ammatory, immune and infec-
tious serological parameters, microbiological and hormonal parameters as well as results from
clinical ANT, odontological, gynaecological and chest X-ray examinations were gathered.
Furthermore, allergological in vitro and an vivo evaluation including oral provocation with food
additives were included. Altogether, de®ned causes could be found in 16.8% of patients.
Whereas in vitro parameters were only rarely changed, foci could be found in up to 50% of
patients, presented mainly as tonsillitis and sinusitis. Physical causes were demonstrated in 31%
of patients. In oral provocation, dyes and preservative agents account for 4.5% of positive reac-
tions, 5.6% to salicylate and 0.9% to bisul®te. Consequently, extensive search for underlying
causes must only follow detailed case history and initially orientating laboratory monitoring.
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Retrospective Study on the Implementation of Guidelines for the Diagnosis of Chronic
Urticaria and/or Angioedema
M.M.A.Kozel, M.C. Ansari Moein, M.M.H.M. Meinardi, and J.D. Bos
Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, the
Netherlands
In 1995 guidelines were introduced for the diagnosis of patients with chronic urticaria (Kozel
MMA, Mekkes JR, Bossuyt PMM, Bos JD: The effectiveness of a history-based diagnostic
approach in chronic urticaria and angioedema. Arch Derm 134:1575±1580, 1998). The center-
piece of this guideline is that extensive laboratory screenings should only be performed in par-
ticular cases, indicated by careful history-taking with the use of a standardized questionnaire. In
this retrospective study we investigated the use and the bene®t of these clinical guidelines.
We analyzed patients records of all patients who visited the outpatient Department of
Dermatology during January 1998 and February 2000. In the 140 patients identi®ed we investi-
gated how often the questionnaire was used, how often routine laboratory tests were performed
at the ®rst visit, and on which information (history-taking, questionnaire, laboratory tests,
provocation tests) the diagnosis was made.
In 71 patients (50.7%) a reason for the urticaria was found. In 63 of the 71 patients (89%) the
cause of the urticaria was already suspected by history taking and in 8 patients (11%) the diag-
nosis was found by the questionnaire. 26 patients had urticaria factitia, the most common ®nd-
ing. In 48 patients the questionnaire was not in the patients ®le. In 89 of 140 patients (64%)
extended laboratory tests, not based on history taking or the questionnaire, were requested at
the ®rst visit and this did not reveal the cause in any patient.
In this retrospective study the identi®cation of a cause for urticaria in 50.7% is slightly higher
than 45.9% of the prospective study. This may be partially explained by 10 patients (7%) with a
contact urticaria to latex. With this study we con®rmed the importance of history taking, the
use of a questionnaire and the test for dermatographism in ®nding the cause of urticaria.
Additionally, routine laboratory tests, even limited, did not help in ®nding the cause of urti-
caria.
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Prevalence of Antibodies to the High-Af®nity IgE Receptor in Chronic Urticaria
M.Sticherling, J. MuÈller, R. Arndt,* E. Christophers, and A. Kromminga*
Department of Dermatology, University of Kiel, Kiel, Germany; *Institute for Immunology, Pathology
and Molecular Biology, Hamburg, Germany
Various etiopathogenic factors are suspected to result in the clinically rather homogenous picture
of urticaria. Cross linkage of surface IgE receptors on mast cells by speci®c antigens is regarded
as one distinct feature in the evolution of urticae. In addition, autoantibodies to the high af®nity
IgE receptor with histamine releasing activity have recently been demonstrated in a subset of
chronic idiopathic urticaria. In the present study, the prelevance of such antibodies was further
evaluated in a total number of 350 different sera from patients with acute, acute intermittent,
chronic persistent and recidivating urticaria. The full-length extra-cellular part of the a-chain
was expressed in the baculovirus system and used to detect antibodies of different sub- and iso-
ptypes by Western blot analysis. In parallel, sera were evaluated for histamine releasing activity
in vitro. IgG antibodies could be detected in 14±50% of sera with highest incidence in chronic
idiopathic recidivating urticaria in contrast to only 25% of normal sera. Only a subset of sera
were shown to induce histamine release in vitro. In such patients, immunosuppressive regimens
directed to modulate pathogenetically relevant autoantibodies may be used successfully in add-
ition to simple antihistamine treatment.
009
Demonstration of Histamine Releasing Autoantibodies in Chronic Idiopathic Urticaria
by a Simpli®ed Histamine Release Test
P.S. Skov, C.R. Johnsen, J.H. Heinig, H.J. Malling, L.K. Poulsen, and C. Bindslev-Jensen
Allergy Unit & Allergy Centre, Copenhagen & Odense, Denmark
Several studies have shown that 40±60% of patients with chronic idiopathic uticaria (CIU) have
autoantibodies to IgE and/or its receptor and that these patients bene®t from immunosuppres-
sive treatment. Autoantibodies have been demonstrated by basophil histamine release which
correlated to the severity of CIU. So far the widespread applications of these ®ndings in the
daily diagnosis of CIU has been limited by the restricted access to a basophil histamine release
test. Based on a commercial assay (HR-Test, RefLab, Denmark) we have developed a simpli®ed
test for detecting histamine releasing activity. Serum from 76 individuals comprising controls
and different forms of urticaria were tested including 27 patients with CIU. In brief 100 ml
diluted serum samples (50, 25 and 12.5%) were incubated with 100 ml dextran-sedimented cells
from one donor and a release of > 12% was considered positive. The results showed that 9 out
of the 27 CIU patients with cholinergic urticaria were positive. Histamine release varied from
serum to serum (range 15±65%) as well as the serum titer inducing a positive response (range
50±12.5%). The results were con®rmed on basophils from two other donors. No patients with
other forms of urticaria or healthy donors were tested positive. Our results suggest that the
HR-Test may be of clinical value in identifying CIU patients who have developed histamine
relasing autoantibodies probably binding to IgE and/or its receptor.
Posters
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Extra- and Intracellular Expression and Regulation of CXCR1 and CXCR2 in HMC-1
Cells and T-Lymphocytes
U. Lippert, K. Zachmann, A. Gruetzkau,* and C. Neumann
Department of Dermatology, Georg-August University, Goettingen, Germany; *Department of
Experimental Dermatology, University Hospital ChariteÂ, Campus Virchow Clinic, Berlin, Germany
In previous studies, we have described the expression of IL-8 and both types of IL-8 receptors,
CXCR1 and CXCR2, in human skin mast cells and the mast cell line HMC-1. Besides extra-
cellular we also demonstrated an intracellular expression of both receptor types. In order to
investigate whether intracellular receptor expression is restricted to mast cells or is a more com-
mon phenomenon, we now extended our studies to T-lymphocytes and asked for the regula-
tion of IL-8 receptor expression after cell stimulation. RT-PCR-analysis demonstrated the
mRNA for CXCR1 and CXCR2 in HMC-1 and T-cells. Extracellular and intracellular
protein expression of CXC-R1 and -R2 was demonstrated in both cell populations, HMC-1
showing the highest percentage. Surprisingly and in contrast to CXCR4, extracellular expres-
sion of CXCR1/R2 was down-regulated after stimulation with PMA and Ca-Ionophore.
CXCR1 and CXCR2 showed different kinetics of down-regulation. Rapid internalization is
the most likely explanation. Internalization may add to the constitutively expressed internal pool
of IL-8 receptors. In further studies we want to investigate whether the intracellular pool con-
tributes to the rapid reappearance of IL-8 receptors on the cell membrane as described for neu-
trophils after their stimulation.
P02
Chronic Urticaria and Angioedema in 140 Patients: a Retrospective Analysis
E.U.Hassler, G. Obermoser, and N. Sepp
Department of Dermatology, University of Innsbruck, Innsbruck, Austria
Between 1993 and 1997, 258 patients had been investigated for chronic urticaria and/or angioe-
dema. Using a standardized questionnaire in a telephone interview, 140 patients (87 women
[64%], 53 men [36%]) were reassessed on the long-term course of their symptoms in spring
2000. In 37% of our patients the symptoms had cleared completely and in 36% there was
marked improvement in the frequency of attacks. 22% reported on no difference and in 4% the
disease had got even worse. Chronic tonsillitis diagnosed by clinical examination and/or an ele-
vated antistreptolysin-titer was seen in 29 patients (21%); tonsillectomy was done on 15 patients,
8 of them being free of symptoms at follow-up. A diagnosis of sinusitis was made in 10 patients
(7%); in only 1 of the 6 treated patients the symptoms were improved afterwards. Six months
after treatment 48 of 49 patients with dental foci still complained of urticaria. Gastroscopic
examination revealed chronic gastritis in 36 of 42 investigated patients (86% of all patients); 60%
of them still suffered both from dyspepsia and urticaria when reassessed. Surprisingly, only in 10
patients Helicobacter pylori was detected by a urease test or histological examination of gastric
mucosa. Unfortunately, eradication therapy was only documented in 2 cases, one of them being
symptom free at follow-up. Milk and fruits were the two most often mentioned alimental trig-
gers. 28% observed an adverse in¯uence of nonsteroidal antiphlogistics. Of considerable interest
is the high rate of atopic disposition in our population (45% of all patients). 47 of them (74%)
still had urticaria at follow-up. Given the long duration of symptoms, it is not surprising that 56
patients asked for paramedical advice, which was found to be helpful by 20. In conclusion, urti-
caria and angioedema had completely resolved in 36%, and the frequency of attacks had signi®-
cantly decreased in 37% at follow-up. Potential risk for a long-term course of urticaria/
angioedema were: long duration of symptoms when ®rst seen in hospital (in 49 of 89 patients
still suffering from urticaria when reassessed; 55%), atopic disposition (in 47 of 89; 53%), gastro-
intestinal symptoms (in 52 of 89; 58%) and intolerance to certain food (in 43 of 89; 48%).
Further studies on a possible role of anti-Fce/IgE autoantibodies in our patients are in progress.
164 ABSTRACTS JID SYMPOSIUM PROCEEDINGS
P03
Chronic Urticaria: In Vivo and In Vitro Evaluation of Autoimmune Etiology in 110
Patients
D. Macchia, M.G. Severino, M. Manfredi,* M.L. Iorno,² V. Volpi,³ and P. Campi
Allergy Clinic, IInd Department of Dermatology, University Clinic, Florence, Italy; *Laboratory, IInd
Department of Dermatology, University Clinic, Florence, Italy; ²Immunohematology, IInd Department of
Dermatology, University Clinic, Florence, Italy; ³U.S.L. 10, IInd Department of Dermatology,
University Clinic, Florence, Italy
The aim of our study was to evaluate the autoimmune etiology of chronic urticaria in 142
patients (pts) selected on the basis of negative tests for other forms of urticaria. Among them,
25% were atopic; adverse reactions to NSAIDs were reported by 41%; 47 was the mean age;
the women to men ratio was 1.5:1. We carried out skin tests with autologous serum: blood was
allowed to clot both at room temperature (``classic test'') and at 37°C (``variant test'') for one
hour before centrifugation. Skin tests were evaluated according to Grattan (Grattan CE:
Histamine-releasing autoantibodies in chronic urticaria. Skin Pharmacol 4 Suppl 1:64±70, 1991).
Classic test yielded positive results in 59% of pts and 25% of healthy control subjects, while vari-
ant test was positive in 84% and 45%, respectively. Antinuclear autoantibodies were found in
14% of pts, antithyroid in 13%, anti gastric parietal cells in 10% and anti pancreatic island in
2%. In vitro histamine release from whole blood of healthy donors yielded positive results in
42% of pts with positive skin test (variant) and in 25% of controls. Studies of HLA class II aplo-
type revealed a statistically signi®cant increase of prevalence of HLA DR 7 (20% vs. 12% of
Italian population). In a two-years follow-up study concerning 70% of our pts, we observed
that the majority had a good quality of life when treated with antihistamine therapy. Only 4 pts
needed steroids and 2 patients Cyclosporin A.
Conclusion The prevalence of positive results of skin test with autologous serum was high, in
particular using the variant test (clotting at 37°C); also in controls it was higher than expected.
More research is needed to evaluate if the variant test is more sensitive or less speci®c, in par-
ticular comparing it with serologic tests for anti-IgE and/or anti-FceRI Aab.
P04
Pathogenic Diagnostic Ef®ciency from Anamnesis and Laboratory Procedures in
Chronic Urticaria
A. GimeÂnez-Arnau, E. Serra-Baldrich, R. M. Pujol VallverduÂ, J. G. and Camarasa
Department of Dermatology, Hospital del Mar, Universitat Autonoma, Barcelona, Spain
Background Chronic urticaria (CU) lasts by de®nition for more than 6 weeks. Older series report
an identi®able cause in only about 20% of cases (Champion RH, Roberts SO, Carpenter RG,
Roger JH: Urticaria and angio-oedema. A review of 554 patients. Br J Dermatol 81:588±597,
1969). This ®gure has much improved and in other series chronic idiopathic urticaria (CIU)
represents 45% (Doeglas HM: Reactions to aspirin and food additives in patients with chronic
urticaria, including the physical urticarias. Br J Dermatol 93:135±144, 1975) or 60±70% (Illig L,
Paul E: Internal causes of urticaria. Verh Dtsch Ges Inn Med 84:919±920, 1978).
Objective To assess the pathogenic diagnostic ef®ciency from the study protocol of CU at the
Department of Dermatology, Hospital del Mar.
Material and Methods The ®rst, non selected, 126 adult patients with CU visiting the Urticaria
Unit were included in a prospective study. All patients were submitted to a detailed anamnesis.
Laboratory procedures and provocation tests were performed in a protocolized way according
to the anamnesic orientation. Among others: a complete study of thyroid autoimmunity, screen-
ing for infections including Helicobacter Pylori and search for autoimmune urticaria with auto-
logous serum skin test were performed.
Results This study included 86 females and 40 males with CU (mean age 41.63614.43 s.d.
years old). 26.19% were physical urticaria and CIU represented 69.84%. Speci®c provocation
test showed 14 dermographic, 13 cholinergic, 7 pressure, 3 solar, 2 afrigore and 2 true aqua-
genic urticaria. Clinical and pathologic ®ndings of urticaria vasculitis were found in 5 (3.9%)
patients. The most relevant ®nding to discuss are: 37.5% of patients showed IgE levels > 100
UI/ml, the incidence of autoimmune thyroid disease was higher than in general population
(26.13%), 61.66% of patients showed a positive breath test or Helicobacter Pylori, autoimmune
urticaria by positive autologous serum skin test was demonstrated in 34.14% of tested patients.
Conclusion The study protocol of CU allowed to ®nd at least one aetiologic, pathogenic or pro-
moting factor in 50% of patients. Most cases cleared with antihistamines but severe autoimmune
urticaria needed and succesfully responded to immunomodulatory drugs.
P05
A Male Case of Adult Onset Mastocytosis with Relatively Rapid Spread of Mast Cells
A. Zalewska, B. Dziankowska-Bartkowiak, H. UrbanÄska-Rys,* P. Janowski,² and A. Sysa-
Jedrzejowska
Department of Dermatology, Medical University of Lodz, Lodz; Poland; *Department of Haematology,
Medical University of Lodz, Lodz; Poland; ²Outpatient Department of Baluty Section, Lodz, Poland
We present a male case of a systemic mast cells disease with pronounced skin involvement. In
our patient, aged 53 years, who suffered from asthma for 30 years, skin lesions started to appear
5 years ago, ®rst on the legs and subsequently the lesions spread all over the body including the
face, head and dorsal aspects of the extremities. Skin lesions presented as extremely dark brown
macules, which urticated relatively vaguely after rubbing (Darier's sign). Basic laboratory tests
did not reveal any abnormalities. Histopathological examination from the lesions (Astra blue
stain, Giemsa method and pinacyanol erythrosinate) con®rmed clinical diagnosis of urticaria pig-
mentosa. In radiological examination tubero-®brous lesions in the second segment of the upper
lobe of the left lung were found (Tbc was excluded). This ®nding was con®rmed by CT scan
with some suggestion of the neoplastic process. Bone scintigraphy revealed some gatherings of
the marker in both tarsal bones. This ®nding was con®rmed by NMR suggesting some nonin-
¯ammatory in®ltrate. Bone marrow biopsy and trepanobiopsy revealed multinucleated gather-
ings of mast cells. Features of some dysplasia were noticed in the granulocyte system ± mainly
lack of granules in younger cells. The patient complained from considerable pruritus and was
put on anti H1 antihistamines with quite good effect. For the present moment, the patient
declined any invasive procedures and treatments which would not bring good permanent
results.
P06
Topical Steroid Application under Wet Wrap Occlusion in Mastocytosis
R. Heide, M.A. Middelkamp Hup, H. Langeveld, B. Tank, and A.P. Oranje
Department of Dermato-Venereology, University Hospital, Rotterdam, the Netherlands
Eleven patients with mastocytosis were treated with topical ¯uticason propionate under wet
wrap occlusion. The aim of this project was to study a new treatment strategy using topical ster-
oids. The experimental design was case controlled. Each patient received two dilutions of ¯uti-
cason propionate (10% and 25%) applied daily under a wet wrap occlusion dressing. The
duration of the treatment was 6 weeks. The patients were evaluated at 3, 6, 12 and 24 weeks
after the start of treatment. The evaluation consisted of repeated measurements of routine blood
and urine analysis, including urine N-methylhistamine and serum cortisol. Clinical improvement
was assessed using a semiquantative scoring of mastocytosis (SCORMA). Biopsies from the skin
lesions were obtained, before and six weeks after treatment. A reduction in activity of the skin
lesions, expressed as improvement in the scorma index, was observed in 9/11 cases. The num-
ber of cutaneous mast cells was reduced by 10±60% after treatment. However pigmentation was
only reduced in a minority of the patients treated with wet wrap. It is concluded that wet wrap
treatment for cutaneous mastocytosis may be an option for treating large skin surfaces especially
in children. In adults the spectrum of treatment options is wider, still favourable results may be
achieved using the wet wrap method.
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Comparison of Telangiectases and Mast Cells in Telangiectasia Macularis Eruptiva
Perstans (TMEP) and Generalized Essential Telangiectasia (GET)
N. Haas, B. Algermissen,* A. GruÈtzkau, and B. M. Henz
Department of Dermatology, ChariteÂ, Humboldt University, Berlin, Germany; *Department of Laser
Medicine, Hospital NeukoÈlln, Berlin, Germany
Telangiectases (TE) are thought to occur through the release or activation of vasoactive medi-
ators in association with numerous pathological conditions. TMEP is a clinical variant of masto-
cytosis, whereas GET is not associated with any underlying disease. Our objective was to
elucidate differences in number, distribution, and phenotype of TE and mast cells (MC) in
either condition. We investigated lesional biopsies from a 6-year-old-child with TMEP and a
40-year-old woman with GET as well as normal skin from two controls. Cryostat sections were
stained by APAAP-technique with antibodies to the MC growth factor stem cell factor (SCF)
and to the following MC markers: SCF receptor (c-kit), MC proteases tryptase and chymase,
and FceRI-a chain. To characterize TE, staining was done for collagen type IV, ®bronectin,
laminin, vs. Willebrand-factor, actin, desmin, CD31,HLA-DR, VEGF-R, and PDGF-R.
Results TE were larger, wider and located deeper in the dermis in GET, compared to TMEP.
Vessel walls were positive for collagen type IV, ®bronectin, laminin, CD31, and v. Willebrand-
factor, and negative for actin, desmin, and PGDF-R in both conditions. HLA-DR and VEGF-
R were positive on TE in TMEP only. In the upper dermis, SCF stained vessel walls in
TMEP, but not in TE of the GET lesion. MC located in the vicinity of TE were lower in
number in GET, compared to TMEP, as evidenced by only few c-Kit, tryptase, chymase, and
FcaÊRI-positive MC close to TE in GET. The increase of mast cells in TMEP may be due to
proteolytic cleavage and thus activation of SCF, with subsequent vessel growth due to the
angiogenic action of VEGF and tryptase. For GET, an underlying MC-associated pathomechan-
ism seems unlikely.
P08
Vibratory Angioedema and Pruritus
S. Reimann, S. Guhl, and T. Zuberbier
Department of Dermatology and Allergy, ChariteÂ, Humboldt University, Berlin, Germany
Vibratory angioedema is a rarely mentioned subtype of physical urticaria ®rst described in
young adult patients working with a pneumatic hammer. However many patients describe prur-
itus following everyday vibratory stimuli like riding a bicycle over cobblestone pavement.
Since no data to the prevalence is available in the literature we have started a pilot study investi-
gating by questionnaire a representative group of 81 medical students (mean age: 24 years,
range: 22±37 years) attending the dermatology course.
In 9 of the participants with anamnestic vibratory angioedema and 6 control persons without
these complaints we performed a provocation test by putting one palm on a vortex for 4 min
Before, 5 and 15 min after the provocation blood sample was taken for the measurement of
serum-histamine content from the draining vein. 22.2% of the participants of the questionnaire
stated to have symptoms in the palms after vibratory stimuli. The main symptoms were pruritus
(100%), urticae (16.7%) and angioedema (5.6%). Women were more frequently (2:1) af¯icted.
On provocation only participants with a positive history reacted with erythema and pruritus
(100%), with angioedema of the hand (33.3%), and urticae (22.2%). Study participants with
vibratory angioedema showed a signi®cant (p = 0.001) increase of serum-histamine content after
provocation in contrast to the control group without anamnestic vibratory angioedema.
Although only a small group was examined, it can be stated that the reaction to everyday vibra-
tory stimuli is quite frequent in young adults. In the majority of people only pruritus or urticae
occur instead of the originally described angioedema. This may be regarded as an abortive form
since mast cells are clearly involved, which is shown in the increase of histamine.
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Detection of IgE Antibodies to Helicobacter pylori by Immuno-Blotting Technique
M. Liutu, K. Kalimo, J. Savolainen, and J. Uksila
Department of Dermatology, University of Turku, Turku, Finland
The connection between chronic urticaria and Helicobacter pylori (H. pylori) has been under
interest. We found in our earlier study elevated IgE levels in patients with chronic urticaria and
especially in patients with H. pylori infection, and therefore we wanted to characterize the IgE
inducing structures of H. pylori.
The cultured H. pylori was handled with 10 different ways to ®nd the optimal antigen extract
to be used in the IgE assays. Immunoblotting was used to detect the IgE binding bands.
H. pylori RAST was carried out in 25 H. pylori infected and in 9 noninfected patients with
chronic urticaria.
The largest number of IgE binding bands were found in extracts prepared from the washing
¯uids, while strong heating and denaturing treatments destroyed the epitopes for IgE binding
suggesting that the antigens belonged to the ¯agellary structures of H. pylori. A pool of 2nd and
3rd washing ¯uid and a sonicated extract for 1.5 min after 3rd wash (1:1:2) was chosen to be
used in H. pylori RAST-assay. In H. pylori RAST elevated levels of IgE antobodies to H. pylori
was detected only in one of 25 H. pylori infected patients. All of the H. pylori negative patients
remained negative.
Our results suggest that, although IgE binding bands were found against H. pylori in immuno-
blotting, the development of H. pylori speci®c IgE response is not common.
P10
Helicobacter pylori in Chronic Urticaria
I. LakosÏ-Jukiñ and J. LipozeneÁiñ
Department of Dermatology and Venerology, University Hospital Center, Zagreb, Croatia
Introduction Chronic urticaria (CU) can be de®ned as the occurrence of wheals on a daily or
almost daily basis over a period longer than 6 weeks. The aim of this study was to determine
the possible triggering factors of CU, and to de®ne the importance of Helicobacter pylori in the
etiology of CU.
Methods At the Allergy Unit of the Department of Dermatology and Venerology, Zagreb
University Hospital Center, 154 patients with CU were recorded during a 3-year period (1996
to 1999). According to sex distribution, there were 112 female (72.7%) and 42 (27.3%) male
patients, mean age 43 years. The diagnosis was based on careful clinical history and relevant
laboratory ®ndings. The infection with Helicobacter pylori was evaluated by commercial serolo-
gic tests, ELISA and complement ®xation test which detect speci®c IgG antibodies, or by endo-
scopy with biopsy.
Results Focal infection as the possible eliciting factor of CU was found in 85 (52.59%) of 154
patients, mostly Candida spp in stool (n=36; 23.37%), parasitic infestation (n=12; 7.79%), and
streptococcal pharyngitis (n=10; 6.49%). Concerning focal infections, serologic tests or endo-
scopy with biopsy revealed Helicobacter pylori in 14 (9.09%) patients. Thyroid autoimmunity and
mental disorders were diagnosed in 4 (2.59%) patients each. Taken together, we identi®ed a
relevant etiopathologic factor of CU in 89 (57.79%) cases, whereas 65 (42.21%) patients were
considered to suffer from idiopathic urticaria.
Conclusion CU is a frustrating problem for both the physician and patient. Serious disabilities of
patients with CU are the loss of sleep and energy, social isolation, including altered emotional
reactions and dif®culties in some aspects of daily living. Thus, the search for possible etiopatho-
genetic factor is of great importance. The measurement of Helicobacter pylori speci®c antibodies
or gastroscopy should always be included in the diagnostic procedure for chronic urticaria.
P11
Helicobacter pylori Speci®c Cellular Immune Response in Chronic Urticaria Patients
B. HidveÂgi, R. GonzaÂlez-Cabello, E. TemesvaÂri, A. SzentmihaÂlyi, M. BroÂzik, B. Fekete,
A. HorvaÂth, and P. Gergely
Central Laboratory of Immunology, Department of Dermato-Venerology, Semmelweiss University,
Budapest, Hungary
Chronic urticaria is a common skin disorder the cause of which is unknown in the majority of
the cases. Helicobacter pylori, the most important etiologic factor of gastritis and peptic ulcer, has
recently been associated with several extradigestive diseases. Previous studies have reported
bene®cial effects of Helicobacter pylori eradication on chronic urticaria, but contradictory results
were also published. Peripheral blood mononuclear cells (PBMC) of 24 chronic idiopathic urti-
caria patients (13 seropositive/11 seronegative) and 18 healthy controls (9 seropositive/9 serone-
gative) were stimulated with whole heat-killed Helicobacter pylori (106±108 bacteria/well),
mitogens PHA (2 mg/ml) and PWM (5 mg/ml). Helicobacter speci®c IgG antibody response
was determined by commercially available enzyme linked immunosorbent assay (Varelisa).
There were signi®cantly higher proliferative responses both to whole heat-inactiveted
Helicobacter pylori (p = 0.015) and PHA (p = 0.007) in 6±7 day cultures of peripheral blood
mononuclear cell in chronic idiopathic urticaria patients than in healthy controls. We found a
tendency to exhibit a higher proliferative response to Helicobacter antigens and mitogens in ser-
opositive than in seronegative ones. Our results support that there is an increased T-cell reactiv-
ity in chronic idiopathic urticaria which is further enhanced in the presence of Helicobacter.
Helicobacter pylori therefore plays a triggering role in the pathogenesis of chronic idiopathic urti-
caria.
P12
Parvovirus B19 in Chronic Urticaria Patients
K. Lammintausta, T. Vuorinen, S. Nikkari, and P. Kotilainen
Department of Dermatology, University Central Hospital, Turku, Finland
The aetiology of chronic urticaria (CU) is not known. However, in some cases infectious agents
have been suggested as triggering factors. When a 16-year-old-male with a history of a recent
parvovirus infection developed CU, the suspicion arose that parvovirus B19 could have a role
in the development of his disease. Parvovirus B19 gene sequences were detected from a skin
biopsy specimen of this patient. Thereafter, a more extensive study in 36 CU patients was done
by ampli®cation of parvovirus B19 sequences from skin samples using two sets of primers and a
probe. Molecular ampli®cation of the human b-globin was used as a methodologic control.
B19 DNA was detected in 18/36 (50%) skin biopsy samples of the CU patients. Interestingly,
14/22 (64%) skin biopsy samples from healthy controls also harbored parvovirus B19 sequences.
All 32 persons positive for B19 DNA had circulating IgG-class antibodies to B19 major struc-
tural protein VP2.
Conclusion Parvovirus B19 DNA is commonly detected in the human skin. Therefore, the asso-
ciation between parvovirus B19 infection and CU remains uncertain.
P13
Parasite-Induced Urticaria ± Cases and Hints
P. Schmid(-Grendelmeier), C. Hatz, H.-U. Simon, and B. WuÈthrich*
Swiss Institute for Allergy & Asthma Research, Davos; Swiss Tropical Institute, Basel, Switzerland;
*Allergy Unit, Department of Dermatology, ZuÈrich, Switzerland
Parasites are frequently argued as a cause in urticaria, although according investigations often
result negative. We present 2 cases of parasite-induced urticaria and give hints for a rational
diagnostic procedure.
A 67-year-old-man presented with chronic intermittent urticaria and Quincke's oedema during
the last 8 years, accompanied by lash-like urticarial ¯ares visible for several hours. The main
abnormal ®ndings were blood eosinophilia (650 cells/ml) and highly elevated total IgE (2040),
but a negative allergological investigation. On the other hand a positive EIA against
Strongyloides-speci®c IgE and larvae of Strongyloides stercoralis in the stool were found. The para-
site was possibly acquired in Brazil 9 years ago. The lash-like ¯ares can retrospectively be inter-
preted as ``larva currens'' ± a phenomenon typical for Strongyloidosis. Treatment with
Albendazol (70 mg/day) for 10 days led to resolvement of the urticaria within a few months.
Also in a tropical area, a 38-year-old-man began to suffer from urticaria whenever in contact
with cold water; a positive ice cube test proved the diagnosis of a cold-induced urticaria. Stool
parasitology revealed a strong presence of Giardia lamblia. Under treatment with Tinidazol (2 g
single dose) the cold urticaria resolved within a few days. 2 additional re-infestations with giar-
diasis were accompanied again by cold urticaria, also with rapid relief after antiparasitic treat-
ment.
Urticaria due to parasites should be considered in all patients with a history of a tropical resi-
dency. Also intake of exotic food such as raw ®sh is a potential source of parasites known to
cause urticaria (e.g. Anisakiasis; Gnathostomiasis). Marked blood eosinophilia and/or markedly
elevated total IgE should in addition lead to a parasitological examination in urticaria patients.
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